| The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation P Garnero, M Ferreras, MA Karsdal, R Nicamhlaoibh, J Risteli, O Borel, ... Journal of bone and Mineral Research 18 (5), 859-867, 2003 | 443 | 2003 |
| Local communication on and within bone controls bone remodeling K Henriksen, AV Neutzsky-Wulff, LF Bonewald, MA Karsdal Bone 44 (6), 1026-1033, 2009 | 290 | 2009 |
| Republished: Value of biomarkers in osteoarthritis: current status and perspectives M Lotz, J Martel-Pelletier, C Christiansen, ML Brandi, O Bruyère, ... Postgraduate medical journal 90 (1061), 171-178, 2014 | 264 | 2014 |
| Matrix metalloproteinase-dependent activation of latent transforming growth factor-β controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis MA Karsdal, L Larsen, MT Engsig, H Lou, M Ferreras, A Lochter, ... Journal of Biological Chemistry 277 (46), 44061-44067, 2002 | 250 | 2002 |
| Are nonresorbing osteoclasts sources of bone anabolic activity? MA Karsdal, TJ Martin, J Bollerslev, C Christiansen, K Henriksen Journal of bone and mineral research 22 (4), 487-494, 2007 | 235 | 2007 |
| Proteinases in bone resorption: obvious and less obvious roles JM Delaissé, MT Engsig, V Everts, M del Carmen Ovejero, M Ferreras, ... Clinica Chimica Acta 291 (2), 223-234, 2000 | 235 | 2000 |
| Should subchondral bone turnover be targeted when treating osteoarthritis? MA Karsdal, DJ Leeming, EB Dam, K Henriksen, P Alexandersen, ... Osteoarthritis and cartilage 16 (6), 638-646, 2008 | 213 | 2008 |
| The future of blood-based biomarkers for Alzheimer's disease K Henriksen, SE O’Bryant, H Hampel, JQ Trojanowski, TJ Montine, ... Alzheimer's & Dementia 10 (1), 115-131, 2014 | 192 | 2014 |
| Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use VB Kraus, FJ Blanco, M Englund, MA Karsdal, LS Lohmander Osteoarthritis and Cartilage 23 (8), 1233-1241, 2015 | 190 | 2015 |
| Osteoclast activity and subtypes as a function of physiology and pathology—implications for future treatments of osteoporosis K Henriksen, J Bollerslev, V Everts, MA Karsdal Endocrine reviews 32 (1), 31-63, 2011 | 166 | 2011 |
| Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity MA Karsdal, SH Madsen, C Christiansen, K Henriksen, AJ Fosang, ... Arthritis research & therapy 10 (3), R63, 2008 | 166 | 2008 |
| The disease modifying osteoarthritis drug (DMOAD): is it in the horizon? P Qvist, AC Bay-Jensen, C Christiansen, EB Dam, P Pastoureau, ... Pharmacological research 58 (1), 1-7, 2008 | 165 | 2008 |
| RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism K Henriksen, M Karsdal, JM Delaissé, MT Engsig Journal of Biological Chemistry 278 (49), 48745-48753, 2003 | 163 | 2003 |
| The chloride channel inhibitor NS3736 prevents bone resorption in ovariectomized rats without changing bone formation S Schaller, K Henriksen, C Sveigaard, AM Heegaard, N Hélix, M Stahlhut, ... Journal of Bone and Mineral Research 19 (7), 1144-1153, 2004 | 158 | 2004 |
| Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption MA Karsdal, K Henriksen, MG Sørensen, J Gram, S Schaller, MH Dziegiel, ... The American journal of pathology 166 (2), 467-476, 2005 | 155 | 2005 |
| The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? F Genovese, AA Manresa, DJ Leeming, MA Karsdal, P Boor Fibrogenesis & tissue repair 7 (1), 4, 2014 | 154 | 2014 |
| Extracellular matrix remodeling: the common denominator in connective tissue diseases possibilities for evaluation and current understanding of the matrix as more than a … MA Karsdal, MJ Nielsen, JM Sand, K Henriksen, F Genovese, ... Assay and drug development technologies 11 (2), 70-92, 2013 | 154 | 2013 |
| Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study RG Jenkins, JK Simpson, G Saini, JH Bentley, AM Russell, R Braybrooke, ... The lancet Respiratory medicine 3 (6), 462-472, 2015 | 153 | 2015 |
| Transforming growth factor-β controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression MA Karsdal, P Hjorth, K Henriksen, T Kirkegaard, KL Nielsen, H Lou, ... Journal of Biological Chemistry 278 (45), 44975-44987, 2003 | 153 | 2003 |
| An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice DJ Leeming, P Alexandersen, MA Karsdal, P Qvist, S Schaller, LB Tanko European journal of clinical pharmacology 62 (10), 781-792, 2006 | 142 | 2006 |
Anne Bay-JensenHead of RheumatologyBekræftet mail på nordicbio.com